Description

Description

Sita-Met 50/850mg Tablet is a mid-strength fixed-dose combination medicine designed for adults with type 2 diabetes mellitus who need a step up from the lower 50/500mg strength but do not yet require the maximum 50/1000mg dose. It brings together Sitagliptin, a DPP-4 inhibitor, and Metformin, a biguanide, in one tablet, giving patients the convenience of dual-action blood sugar control without the need to take two separate medicines. This particular strength is often used as an intermediate step during dose titration, allowing doctors to gradually increase Metformin exposure while monitoring how well a patient tolerates the medicine before moving to a higher dose if needed. The pack contains 14 tablets, generally intended for a two-week course as determined by the treating physician. As with all diabetes combination therapies, this tablet should be used only under proper medical supervision, accompanied by periodic monitoring of blood glucose and kidney function.

Ingredients

Each Sita-Met 50/850mg Tablet contains Sitagliptin 50mg together with Metformin Hydrochloride 850mg as the active pharmaceutical ingredients. Sitagliptin acts by prolonging the effect of the body’s natural incretin hormones, encouraging appropriate insulin release after meals, while Metformin at this intermediate strength works to reduce liver glucose output, slow intestinal absorption of sugar, and enhance the sensitivity of muscle and fat tissue to insulin. The tablet also contains inactive excipients such as povidone, microcrystalline cellulose, sodium starch glycolate, magnesium stearate, and a smooth film coating that supports easy swallowing and protects the tablet’s contents.

Dosage Form

Sita-Met 50/850mg is manufactured as a film-coated oral tablet, formulated to deliver both active ingredients in a single dose while remaining comfortable to swallow. The tablets are supplied in blister packaging that guards against moisture and light exposure, helping the medicine retain its effectiveness through to the labelled expiry date.

Uses

Sita-Met 50/850mg Tablet is used to improve blood sugar control in adults with type 2 diabetes mellitus, particularly those who need a moderately stronger dose than the lowest combination strength but are not yet ready for, or do not require, the highest available dose. The Sitagliptin component helps regulate insulin secretion in response to rising blood sugar and limits unnecessary glucose release from the liver, while the Metformin component at this strength further reduces hepatic glucose production and improves how effectively the body’s cells respond to insulin. This tablet is often prescribed during a gradual dose-adjustment process, or for patients whose glycemic targets are better met at this intermediate level, and is generally used alongside a structured diet and exercise plan to support long-term diabetes control and reduce the risk of complications.

How to Use

Sita-Met 50/850mg Tablet should be taken exactly as directed by the prescribing doctor, usually with meals to help minimize the digestive discomfort that can be associated with the Metformin component. The tablet should be swallowed whole with a sufficient amount of water, and it should not be crushed or chewed unless specifically advised by a healthcare professional. Doctors often prescribe this strength as part of a step-by-step titration plan, so patients should follow the exact schedule given rather than adjusting the dose independently. Taking the tablet at a consistent time each day helps maintain steady blood sugar control. If a dose is missed, it should be taken as soon as it is remembered, unless the next dose is close, in which case the missed dose should be skipped rather than taking two doses together.

Side Effects

Sita-Met 50/850mg Tablet may cause side effects related to either of its two active components. Gastrointestinal effects such as nausea, mild diarrhea, bloating, or a metallic taste are commonly linked to the Metformin portion and often lessen as treatment continues. Side effects associated with Sitagliptin may include headache, sore throat, or symptoms resembling an upper respiratory infection. Some patients may also notice a reduced appetite during the initial period of treatment. In rare instances, more serious reactions can occur, including lactic acidosis (recognizable by unusual muscle pain, difficulty breathing, or extreme weakness), signs of pancreatitis, or allergic responses such as skin rash or swelling. Any severe or unusual symptoms should be reported to a doctor promptly, and the medicine should not be continued without medical advice in such cases.

Pregnancy & Breastfeeding

The use of Sita-Met 50/850mg Tablet during pregnancy is generally avoided unless a physician determines that it is clearly necessary, since blood sugar control during pregnancy is usually managed through alternative approaches better suited to that stage of life. Women who are pregnant, planning a pregnancy, or currently breastfeeding should inform their doctor before starting or continuing this medicine so that safer options can be explored if required. As both active ingredients may pass into breast milk to some degree, breastfeeding mothers should seek individualized medical guidance before use.

Storage Instructions

Sita-Met 50/850mg Tablets should be stored in a cool, dry place away from direct sunlight and excess humidity, ideally at a temperature below 30°C. The tablets should be kept in their original blister strip until they are ready to be used, and stored securely out of the reach and sight of children and pets. Avoid keeping this medicine in bathrooms or other damp areas, and never allow the tablets to freeze. Always check the expiry date before use, and dispose of any expired or unused tablets responsibly through appropriate medicine disposal services rather than household waste or sinks.

FAQS

Q1. Why would a doctor choose the 850mg strength over 500mg or 1000mg?
This intermediate strength is often used during gradual dose titration, allowing the doctor to increase the Metformin dose in a controlled step before considering the maximum strength.

Q2. Should this tablet be taken before or after food?
It is generally recommended to take it with or just after meals to help reduce stomach-related side effects from the Metformin component.

Q3. Can this strength be used long-term?
Yes, many patients continue on this strength long-term if it successfully maintains their target blood sugar levels, subject to regular doctor review.

Q4. Is monitoring different at this dose compared to the 500mg strength?
Monitoring principles remain similar, including periodic kidney function and blood sugar checks, though the doctor may adjust frequency based on individual response.

Q5. What if stomach upset continues even after a few weeks?
Persistent digestive symptoms should be reported to the doctor, who may consider adjusting the dose, timing, or exploring an alternative treatment plan.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.